Rare diseases
Investigational molecules
Locations
8888 Lvyou Road, High Tech Zone, 250104
Qilu Pharmaceutical Co. Ltd. is active in non-small cell lung cancer research, with clinical interest centered on adjuvant therapy and immuno-oncology treatment development. The sponsor’s work in this area includes evaluation of pharmacokinetics and pharmacodynamics for oncology-focused candidates.
Its oncology portfolio reflects interest in therapies used to support cancer treatment and in the characterization of biologic agents relevant to PD-1/PD-L1-linked pathways.
Qilu Pharmaceutical Co. Ltd. runs clinical trials in conditions such as Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GreeceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
